세계의 무지외반증 수술 시장 : 제품별, 환자 유형별, 유형별, 최종 사용자별, 지역별 - 예측(-2029년)

The bunion surgery market is expected to grow by USD 606.1 million in 2029 from USD 458.4 million in 2024 at a growth rate of 5.7% during the forecast period. Increasing numbers of bunion surgeries are the factor driving the growth of the bunion surgery market. With the continued increase in incidence of bunions, especially amongst the elderly population, the demands for surgical treatments to correct deformity increase. Additionally, increasing awareness of effective treatment alternatives and the availability of advanced techniques, including minimally invasive procedures, has increased the number of patients for bunion surgery.

"Hospitals segment is expected to have the fastest growth rate in the bunion surgery market, by end user, during the forecast period."

Based on end user, the bunion surgery market is segmented into hospital, ambulatory surgery centers, and orthopedic clinics. The hospital segment is expected to have the highest CAGR during the forecasted period. The growth rate can be attributed to the availability of advance surgical techniques, and ongoing investment in healthcare infrastructure. As hospital continues to expand and adopt new and advance technologies they remain the preferred choice for complex bunion surgery.

"Minimally invasive surgeries segment accounted for the highest growth rate in the bunion surgery market, by type, during the forecast period."

Based on type, the bunion surgery market is bifurcated into traditional surgeries and minimally invasive surgeries. The minimally invasive surgeries segment is expected to grow at the highest CAGR in the market of bunion surgery mainly due to advancement in technological such as specialized surgical tools. These surgeries have enhanced the precision and reliability of bunion surgery, making them more effective and accessible.

"Asia Pacific: The fastest-growing region in bunion surgery market."

The global market for bunion surgery is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. Notably, the Asia-Pacific region marks the highest CAGR in the bunion surgery market, due to increasing investments into healthcare infrastructure. In addition to this, the number of rapidly aging patients strongly demands effective treatments for diseases related to age including bunion. The growing medical tourism activities in the APAC region also happen to be of great influence for the market, given the rapid increase of patients seeking advanced surgical treatments and high-class healthcare services. These factors, collectively, have put the APAC region on a growth trajectory for bunion surgery markets.

The break-up of the profile of primary participants in the bunion surgery market:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%

The key players in the market are Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew (UK), Paragon 28, Inc (US), CONMED Corporation (US), Zimmer Biomet (US), Treace Medical Concepts, Inc (US), Enovis Corporation (US), Medartis AG (Switzerland), Double Medical Technology Inc. (China), Arthrex, Inc. (US), Acumed LLC (US), Merete GmbH (Germany), BioPro, Inc. (US), Dieter Marquardt Medizintechnik GmbH (Germany), Exactech, Inc. (US), JEIL MEDICAL CORPORATION (South Korea), Ortimplant Orthopaedics & Medical Devices (Turkey), Astrolabe (Portugal), Extremity Medical (US), Voom Medical Devices (US), INVAMED (US), Auxein (India), Aysam Orthopaedics & Medical Devices (Turkey), and Deva TIbbi Malzemeler (Turkey).

Research Coverage:

This research report categorizes the bunion surgery market by product (correction systems and implants & accessories), by patient type (adult patients and pediatric patients), by type (traditional surgeries and minimally invasive surgeries), by end user (hospitals, ambulatory surgery centers, and orthopedic clinics), and by region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the bunion surgery market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the bunion surgery market. Competitive analysis of upcoming startups in the bunion surgery market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall bunion surgery market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Increasing burden of bunion surgery, expanding geriatric population, rising incidence of sports injuries and rheumatoid arthritis, growing demand for minimally invasive surgery, increasing research funding and grants ), opportunities (rising number of hospitals and surgical centers worldwide, growth opportunities in emerging markets), restraints (high cost of surgery), and challenges (availability of non-surgical alternatives) influencing the growth of the bunion surgery market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the bunion surgery market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the bunion surgery market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bunion surgery market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew (UK), Paragon 28, Inc (US), and Zimmer Biomet (US).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH APPROACH
  • 2.2.1 SECONDARY DATA
    • 2.2.1.1 Key data from secondary sources
  • 2.2.2 PRIMARY DATA
    • 2.2.2.1 Primary sources
    • 2.2.2.2 Key data from primary sources
    • 2.2.2.3 Key industry insights
    • 2.2.2.4 Breakdown of primary interviews
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.1.1 Approach 1: Company revenue estimation approach
    • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.3.1.3 Growth forecast
    • 2.3.1.4 CAGR projections
  • 2.3.2 TOP-DOWN APPROACH
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.5 MARKET SHARE ASSESSMENT
• 2.6 RESEARCH ASSUMPTIONS
  • 2.6.1 PARAMETRIC ASSUMPTIONS
  • 2.6.2 GROWTH RATE ASSUMPTIONS
• 2.7 RESEARCH LIMITATIONS
• 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 BUNION SURGERY MARKET OVERVIEW
• 4.2 BUNION SURGERY MARKET, BY PRODUCT, 2024 VS. 2029
• 4.3 BUNION SURGERY MARKET, BY PATIENT TYPE, 2024 VS. 2029
• 4.4 BUNION SURGERY MARKET, BY TYPE, 2024 VS. 2029
• 4.5 BUNION SURGERY MARKET, BY END USER, 2024 VS. 2029
• 4.6 BUNION SURGERY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing burden of bunion surgeries
    • 5.2.1.2 Expanding geriatric population
    • 5.2.1.3 Rising incidence of sports injuries and rheumatoid arthritis
    • 5.2.1.4 Growing demand for minimally invasive surgeries
    • 5.2.1.5 Increasing research funding and grants
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of surgeries
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising number of hospitals and surgical centers worldwide
    • 5.2.3.2 Growth opportunities in emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Availability of non-surgical alternatives
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND OF BUNION SURGERY PRODUCTS
  • 5.4.2 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS, BY REGION
  • 5.4.3 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS, BY KEY PLAYER
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Implants
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 Correction systems
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 Splints
• 5.10 PATENT ANALYSIS
• 5.11 TRADE ANALYSIS
  • 5.11.1 IMPORT DATA FOR HS CODE 9021
  • 5.11.2 EXPORT DATA FOR HS CODE 9021
• 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.13 REGULATORY LANDSCAPE
  • 5.13.1 REGULATORY ANALYSIS
    • 5.13.1.1 North America
      • 5.13.1.1.1 US
      • 5.13.1.1.2 Canada
    • 5.13.1.2 Europe
    • 5.13.1.3 Asia Pacific
      • 5.13.1.3.1 China
      • 5.13.1.3.2 Japan
      • 5.13.1.3.3 India
    • 5.13.1.4 Latin America
      • 5.13.1.4.1 Brazil
      • 5.13.1.4.2 Mexico
    • 5.13.1.5 Middle East & Africa
  • 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.14 PORTER'S FIVE FORCES ANALYSIS
  • 5.14.1 THREAT OF NEW ENTRANTS
  • 5.14.2 THREAT OF SUBSTITUTES
  • 5.14.3 BARGAINING POWER OF BUYERS
  • 5.14.4 BARGAINING POWER OF SUPPLIERS
  • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.15.2 BUYING CRITERIA
• 5.16 IMPACT OF AI ON BUNION SURGERY MARKET
  • 5.16.1 INTRODUCTION
  • 5.16.2 MARKET POTENTIAL OF AI
  • 5.16.3 AI USE CASES
  • 5.16.4 FUTURE OF AI/GEN AI

6 BUNION SURGERY MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 IMPLANTS & ACCESSORIES
  • 6.2.1 SHIFTING DEMOGRAPHIC PATTERN TO FACILITATE GROWTH
• 6.3 CORRECTION SYSTEMS
  • 6.3.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES TO DRIVE MARKET

7 BUNION SURGERY MARKET, BY PATIENT TYPE

• 7.1 INTRODUCTION
• 7.2 ADULT PATIENTS
  • 7.2.1 CHANGING LIFESTYLE PREFERENCES TO PROMOTE GROWTH
• 7.3 PEDIATRIC PATIENTS
  • 7.3.1 INCREASING PREVALENCE OF FLAT FEET AND CEREBRAL PALSY TO AID GROWTH

8 BUNION SURGERY MARKET, BY TYPE

• 8.1 INTRODUCTION
• 8.2 TRADITIONAL SURGERIES
  • 8.2.1 RISING POOL OF ARTHRITIS PATIENTS TO EXPEDITE GROWTH
• 8.3 MINIMALLY INVASIVE SURGERIES
  • 8.3.1 GROWING ADVANCEMENTS IN SPECIALIZED SURGICAL TOOLS TO FUEL MARKET

9 BUNION SURGERY MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 INCREASING DEMAND FOR SPECIALIZED TREATMENTS TO SUSTAIN GROWTH
• 9.3 AMBULATORY SURGERY CENTERS
  • 9.3.1 RISING INCLINATION TOWARD LOWER COSTS AND SHORTER PATIENT STAYS TO STIMULATE GROWTH
• 9.4 ORTHOPEDIC CLINICS
  • 9.4.1 GROWING PREFERENCE FOR EFFECTIVE POST-OPERATIVE CARE AND LIMITED HOSPITALIZATION TO BOOST MARKET

10 BUNION SURGERY MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Increasing number of FDA approvals to facilitate growth
  • 10.2.3 CANADA
    • 10.2.3.1 Growing incidence of arthritis to promote growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Increasing incidence of osteoporosis to expedite growth
  • 10.3.3 UK
    • 10.3.3.1 Growing demand for surgical treatments to drive market
  • 10.3.4 FRANCE
    • 10.3.4.1 Presence of robust healthcare system to augment growth
  • 10.3.5 ITALY
    • 10.3.5.1 Growing geriatric population to fuel market
  • 10.3.6 SPAIN
    • 10.3.6.1 Rising prevalence of hallux valgus to encourage growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 Growing public access to modern healthcare to fuel market growth
  • 10.4.3 JAPAN
    • 10.4.3.1 Rise in elderly population to support growth
  • 10.4.4 INDIA
    • 10.4.4.1 High prevalence of arthritis and foot deformities to encourage growth
  • 10.4.5 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Growing cultural focus on appearance to propel market
  • 10.5.3 MEXICO
    • 10.5.3.1 Increased availability of advanced surgical techniques to augment growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 GROWING ADVANCEMENTS IN MEDICAL TECHNOLOGIES TO PROPEL MARKET
  • 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 10.7 GCC COUNTRIES
  • 10.7.1 RISING FOCUS ON ADVANCED HEALTH INFRASTRUCTURE TO DRIVE MARKET
  • 10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BUNION SURGERY MARKET
• 11.3 REVENUE ANALYSIS, 2021-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY VALUATION AND FINANCIAL METRICS
• 11.6 BRAND/PRODUCT COMPARISON
  • 11.6.1 SMITH+NEPHEW
  • 11.6.2 ZIMMER BIOMET
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
  • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.7.5.1 Company footprint
    • 11.7.5.2 Region footprint
    • 11.7.5.3 Product footprint
    • 11.7.5.4 Patient type footprint
    • 11.7.5.5 Type footprint
• 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 RESPONSIVE COMPANIES
  • 11.8.3 DYNAMIC COMPANIES
  • 11.8.4 STARTING BLOCKS
  • 11.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023
    • 11.8.5.1 Detailed list of key startups/SMEs
    • 11.8.5.2 Competitive benchmarking of startups/SMEs
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES
  • 11.9.2 DEALS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 STRYKER
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches
      • 12.1.1.3.2 Deals
      • 12.1.1.3.3 Expansions
      • 12.1.1.3.4 Other developments
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Right to win
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 ZIMMER BIOMET
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
      • 12.1.2.2.1 Deals
    • 12.1.2.3 MnM view
      • 12.1.2.3.1 Right to win
      • 12.1.2.3.2 Strategic choices
      • 12.1.2.3.3 Weaknesses and competitive threats
  • 12.1.3 JOHNSON & JOHNSON SERVICES, INC.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches
      • 12.1.3.3.2 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Right to win
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 SMITH+NEPHEW
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Deals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Right to win
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses and competitive threats
  • 12.1.5 ENOVIS CORPORATION
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Deals
      • 12.1.5.3.2 Expansions
  • 12.1.6 PARAGON 28, INC.
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product launches
      • 12.1.6.3.2 Deals
    • 12.1.6.4 MnM view
      • 12.1.6.4.1 Right to win
      • 12.1.6.4.2 Strategic choices
      • 12.1.6.4.3 Weaknesses and competitive threats
  • 12.1.7 TREACE MEDICAL CONCEPTS, INC.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product launches
      • 12.1.7.3.2 Deals
      • 12.1.7.3.3 Other developments
  • 12.1.8 CONMED CORPORATION
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
  • 12.1.9 MEDARTIS AG
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches
      • 12.1.9.3.2 Deals
  • 12.1.10 DOUBLE MEDICAL TECHNOLOGY INC.
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
  • 12.1.11 ARTHREX, INC.
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Product launches
  • 12.1.12 ACUMED LLC
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Expansions
  • 12.1.13 MERETE GMBH
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
  • 12.1.14 VOOM MEDICAL DEVICES
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
  • 12.1.15 BIOPRO, INC
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
• 12.2 OTHER PLAYERS
  • 12.2.1 DIETER MARQUARDT MEDIZINTECHNIK GMBH
  • 12.2.2 EXTREMITY MEDICAL
  • 12.2.3 ASTROLABE
  • 12.2.4 INVAMED
  • 12.2.5 ORTIMPLANT ORTHOPAEDICS & MEDICAL DEVICES
  • 12.2.6 AUXEIN
  • 12.2.7 EXACTECH, INC.
  • 12.2.8 JEIL MEDICAL CORPORATION
  • 12.2.9 AYSAM ORTHOPAEDICS & MEDICAL DEVICES
  • 12.2.10 DEVA TIBBI MALZEMELER

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS